Windlas Biotech Limited (WINDLAS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 15.49B |
| Enterprise Value | 15.83B |
| P/E Ratio | 27.13 |
| PEG Ratio | 3.29 |
| Price/Sales Ratio | 2.01 |
| Price/Book Ratio | 3.12 |
| Enterprise/Revenue | 2.04 |
| Enterprise/EBITDA | 15.09 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.12 |
Income Statement
| Revenue | 9.04B |
| Revenue/Share | 428.58 |
| Gross Profit | 1.64B |
| EBITDA | 1.05B |
| Net Income | 664.56M |
| Diluted EPS | 31.15 |
Balance Sheet
| Total Cash | 2.7B |
| Total Cash/Share | 128.08 |
| Total Debt | 352.42M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.95 |
| Book Value Per Share | 275.34 |
Price History
| 52-Week Change | -13.49 |
| 52-Week High | 1,097.9 |
| 52-Week Low | 697.4 |
| Moving Average 50 Days | 839.92 |
| Moving Average 200 Days | 813.62 |
Statistics
| Average Volume | 52,341 |
| Shares Outstanding | 21.17M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 6.3 |
| Trailing Annual Dividend Yield | 0.73 |
| Payout Ratio | 0.18 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
